MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-06-30, TNFA has $17,151,103 in assets. $5,550,149 in debts.

Balance Sheets Overview

Current Ratio
92.84%
Debt to Asset Ratio
32.36%
Assets Breakdown
    • Goodwill
    • Marketable securities
    • Investment in oravax medical
    • Others
Liabilities Breakdown
    • Additional paid in capital
    • Accumulated deficit
    • Convertible preferred stock, val...
    • Others

Unit: Dollar
Balance Sheets
2025-06-30
Lease right-of-use
0
Investment in oravax medical
1,500,000
Goodwill
10,498,539
Total non-current assets
11,998,539
Prepaid expenses
1,339,503
Marketable securities
3,605,508
Cash
207,553
Total current assets
5,152,564
Total assets
17,151,103
Due to mymd fl shareholders-Related Party
29,982
Lease liability
0
Dividends payable
2,843,017
Derivative liability
0
Trade and other payables
2,677,150
Total current liabilities
5,550,149
Total liabilities
5,550,149
Convertible preferred stock, value-Series GConvertible Preferred Stock
8,737,000
Convertible preferred stock, value-Series FOne Convertible Preferred Stock
2,065,426
Convertible preferred stock, value-Series FConvertible Preferred Stock
5,130,667
Convertible preferred stock discount-Series GConvertible Preferred Stock
7,544,000
Convertible preferred stock discount-Series FOne Convertible Preferred Stock
2,065,426
Convertible preferred stock discount-Series FConvertible Preferred Stock
0
Convertible preferred stock derivative-Series FConvertible Preferred Stock
0
Total mezzanine equity
6,323,667
Accumulated deficit
-133,849,089
Preferred stock, value-Series DConvertible Preferred Stock
144,524
Common stock, par value 0.001, 1,250,000,000 shares authorized, 29,383,743 and 3,363,603 shares issued and outstanding as of june 30, 2025 and december 31, 2024, respectively
29,384
Additional paid in capital
138,952,468
Total stockholders equity
5,277,287
Total liabilities and stockholders equity
17,151,103
Unit: Dollar

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash$207,553 Marketable securities$3,605,508 Prepaid expenses$1,339,503 Goodwill$10,498,539 Investment in oravaxmedical$1,500,000 Total current assets$5,152,564 Total non-currentassets$11,998,539 Total assets$17,151,103 Total liabilities andstockholders equity$17,151,103 Total stockholdersequity$5,277,287 Total mezzanineequity$6,323,667 Total liabilities$5,550,149 Accumulated deficit-$133,849,089 Convertible preferred stock discount-Series FOne...$2,065,426 Convertible preferred stock discount-Series GConvertible...$7,544,000 Additional paid in capital$138,952,468 Convertible preferredstock, value-Series...$5,130,667 Convertible preferredstock, value-Series...$2,065,426 Total currentliabilities$5,550,149 Common stock, par value0.001, 1,250,000,000...$29,384 Preferred stock,value-Series DConvertible...$144,524 Convertible preferredstock, value-Series...$8,737,000 Trade and otherpayables$2,677,150 Dividends payable$2,843,017 Due to mymd flshareholders-Related Party$29,982

TNF Pharmaceuticals, Inc. (TNFA)

TNF Pharmaceuticals, Inc. (TNFA)